Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency - art. no. R13
Tools
Martin, P, Talabot-Ayer, D, Seemayer, CA, Vigne, S, Lamacchia, C, Rodriguez, E, Finckh, A, Smith, DE, Gabay, C and Palmer, G (2013) Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency - art. no. R13. ARTHRITIS RESEARCH & THERAPY.
Official URL: http://sfx.eu.novartis.net:9004/sfx_local?sid?url_...
Item Type: | Article |
---|---|
Additional Information: | pubid: 80 nvp_institute: NIBR contributor_address: Univ Hosp Geneva, Dept Internal Med, Div Rheumatol, CH-1211 Geneva 14, Switzerland, Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland Gaby.Palmer@unige.ch; Novartis Pharma AG, Translat Med, NIBR, CH-4002 Basel, Switzerland ; Univ Hosp Geneva, Dept Internal Med, Div Rheumatol, CH-1211 Geneva 14, Switzerland ; Amgen Inc, Dept Inflammat Res, Seattle, WA 98119 USA ; Univ Hosp Geneva, Dept Internal Med, Div Rheumatol, CH-1211 Geneva 14, Switzerland; Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; Palmer, G; Univ Hosp Geneva, Dept Internal Med, Div Rheumatol, 26 Ave Beau Sejour, CH-1211 Geneva 14, Switzerland |
Date Deposited: | 13 Oct 2015 13:13 |
Last Modified: | 13 Oct 2015 13:13 |
URI: | https://oak.novartis.com/id/eprint/21922 |